On January 28, UK Prime Minister Keir Starmer arrived in China for his first official visit, marking the first trip to the country by a British prime minister in eight years. Accompanying him were more than 50 senior executives from leading companies including HSBC, AstraZeneca, Jaguar Land Rover and other firms spanning finance, pharmaceuticals, automotive and energy — setting a clear economic tone for the high-profile visit.
Economic Cooperation Takes Center Stage
As the first UK prime minister to visit China in nearly a decade, Starmer placed economic engagement at the heart of his agenda. The visit comes amid a wave of early-2026 diplomacy, with leaders from France, Germany, Canada and other countries also making trips to China.
Talks focused on multiple pillars of economic cooperation:
• Financial connectivity: UK and Chinese financial regulators are set to discuss enhanced connectivity between London and China's mainland markets, including Shanghai and Shenzhen, alongside cross-border data-sharing mechanisms.
• Healthcare and life sciences: Companies such as AstraZeneca are expected to deepen their presence in China, as both sides seek closer collaboration in pharmaceuticals, healthcare and life sciences.
• Green energy cooperation: Energy supplier Octopus is engaging with China's new energy industry to explore collaboration across renewable and low-carbon sectors.
• Whisky tariff adjustments: Following China's reduction of whisky import tariffs to 10% in 2025, the UK is pushing for further optimization to support its domestic spirits industry.
In addition, the two sides are expected to reach understandings on climate cooperation and the promotion of Chinese language learning.
Why the Urgency Now?
The Starmer government's proactive outreach reflects structural pressures on the UK economy, while trade data underscore the resilience — and shifting dynamics — of UK–China economic ties.
From 2022 to 2024, bilateral trade remained subdued. In contrast, 2025 marked a turning point: UK exports to China rose 8.02% year-on-year, while imports declined by 4.92%, highlighting a sharp divergence from previous trends. The data point both to the rising competitiveness of Chinese products and to the UK market's rigid demand for Chinese supply — key factors driving London's push to stabilize and repair trade relations.
Underlying this urgency are deeper structural realities:
• Growing two-way investment stock signals that UK firms are unwilling to exit the Chinese market, while Chinese capital continues to inject vitality into the UK economy, making further deterioration in trade ties economically costly for Britain.
• Strong product complementarity remains the foundation of bilateral trade, allowing both sides to maintain resilience amid global volatility. The UK is keen to consolidate this “mutual-need” structure while advancing priorities such as whisky tariff optimization and upgraded pharmaceutical cooperation to unlock new growth drivers.
• Domestic economic pressure is intensifying. In 2025, UK economic growth remained volatile, with GDP contracting 0.1% month-on-month in October and expanding only 0.3% in November. Annual losses exceeding £140 billion linked to Brexit have yet to be fully offset.
Against this backdrop, China has become a critical lever for boosting UK GDP and easing employment pressures. An estimated 150,000 UK jobs in sectors such as electric vehicles, photovoltaics and financial services are directly tied to China-related demand chains — deep interdependence that has pushed China cooperation to the top of the Starmer government's economic agenda.
Looking Ahead: Three Key Areas of Cooperation
According to multiple sources, the visit is expected to yield cooperation agreements across several sectors, likely shaping new growth areas for UK–China economic ties:
1. Financial services connectivity
Advancing stock market links between London and China's Shanghai and Shenzhen exchanges, alongside progress on cross-border data sharing — an area of strategic importance for the UK as a global financial hub.
2. Pharmaceuticals and health
New agreements in healthcare, health services and life sciences, leveraging the UK's R&D strengths and China's vast market demand.
3. Green energy and climate cooperation
Building on longstanding collaboration in climate action, with potential advances in new energy technologies and carbon trading market development.
As global economic uncertainty persists, Starmer's China visit signals a pragmatic recalibration of UK foreign economic policy — one that places trade resilience, industrial complementarity and growth-oriented cooperation firmly at its core.